advanced search

INJECTION

ADVANCING CANCER CARE THROUGH ON-BODY SUBCUTANEOUS INJECTIONS: THE ONCOLOGY COMMUNITY’S PERSPECTIVE
EXPERT VIEW
Dr Greg Moakes
ADVANCING CANCER CARE THROUGH ON-BODY SUBCUTANEOUS INJECTIONS: THE ONCOLOGY COMMUNITY’S PERSPECTIVE
Dr Greg Moakes discusses the role that on-body delivery systems have to play in modernising the delivery of oncology drugs, digging into the survey results of over 200 attendees of the American Society of Clinical Oncology 2025 Global Meeting as to their opinions on the place of this pivotal technology in oncological practice.
DEVICE DESIGN TO ADDRESS USABILITY AND MITIGATE USE-RELATED RISKS – A MEDICAL AFFAIRS AND HUMAN FACTORS PERSPECTIVE
WEARABLES
Dr Sylvine Raverdy-Wilson
BD (Becton Dickinson & Company)
DEVICE DESIGN TO ADDRESS USABILITY AND MITIGATE USE-RELATED RISKS – A MEDICAL AFFAIRS AND HUMAN FACTORS PERSPECTIVE
Dr Sylvine Raverdy-Wilson deep dives into the device constituent of drug-device combination product design and shares perspectives through the Use-Related Risk Analysis methodology with a focus on the BD Libertas™ Wearable Injector.
VISTA BY TXSPHERE: TRAVERSING THE LIMITATIONS OF SMALL-VOLUME BIOLOGICS
WEARABLES
Dr Chaoyoung Lee
TxSphere
VISTA BY TXSPHERE: TRAVERSING THE LIMITATIONS OF SMALL-VOLUME BIOLOGICS
Dr Chaoyoung Lee and Mike Stout unveil an innovative addition to TxSphere's wearable platform, Vista, designed to improve on efficiency goals, adapt to varied drug formulations and advance beyond the requirements of low-volume drug delivery.
INJECTING DRUGS DIRECTLY INTO THE BODY: HOW ON-BODY DELIVERY SYSTEMS ARE REVOLUTIONISING THERAPY
WEARABLES
Peter Schmidt
ZwickRoell
INJECTING DRUGS DIRECTLY INTO THE BODY: HOW ON-BODY DELIVERY SYSTEMS ARE REVOLUTIONISING THERAPY
Peter Schmidt discusses the advantages of on-body delivery systems and what makes them special, going on to consider the significant role that they are expected to play in the future of injection technology for the pharmaceutical and medical fields, as well as the role that comprehensive testing plays in bringing this technology to patients.
ACCELERATING DEVELOPMENT OF ELECTROMECHANICAL DELIVERY SYSTEMS VIA MODULAR INTEGRATION
WEARABLES
Nicholas Ciccarelli
Kymanox
ACCELERATING DEVELOPMENT OF ELECTROMECHANICAL DELIVERY SYSTEMS VIA MODULAR INTEGRATION
Nicholas Ciccarelli, Andrew King, Dr Marcus Herrmann and Dr Thomas Roschke, discuss the insights gained in the product development process from the recent collaboration between the two companies, with Kymanox managing the overall system integration and Johnson MedTech tackling the specific design of the drive system within the designated product specification.
SAFE AND SKIN-FRIENDLY MANUFACTURING OF MEDICAL WEARABLES WITH ULTRASONIC WELDING
EXPERT VIEW
Michael Boerner
SAFE AND SKIN-FRIENDLY MANUFACTURING OF MEDICAL WEARABLES WITH ULTRASONIC WELDING
Michael Boerner looks at the key factors for designing skin-friendly medical wearables and how to manufacture them safely, automatically and sustainably.
SELF-INJECTION DEVICE MANUFACTURING IN A DYNAMIC WORLD
INDUSTRIALISATION
Philipp Richard
Ypsomed
SELF-INJECTION DEVICE MANUFACTURING IN A DYNAMIC WORLD
Philipp Richard scrutinises the efficient production of self-injection devices in the pharma industry and describes Ypsomed’s own platforms for developing these devices, highlighting the need to be adaptable and resilient to the rapidly evolving world of drug development. He provides valuable insights into the ways in which the flexible manufacture of self-injection devices might be achieved.
Interview: SHL Advantec – SHL Medical’s New Manufacturing Equipment Sub-Group
INTERVIEW
Gilbert Fluetsch
SHL Advantec
Interview: SHL Advantec – SHL Medical’s New Manufacturing Equipment Sub-Group
Gilbert Fluetsch discusses the establishment of SHL Advantec and the foundation it has built as SHL Medical’s in-house equipment specialist. Mr Fluetsch also looks at the role of modular platforms in scaling production and how the company’s global network is designed to support the changing landscape of medical and pharma manufacturing.
FINDING COMMON GROUND: FACTORS FOR ESTABLISHING AND SAFEGUARDING SHELF LIFE IN COMBINATION PRODUCTS
INDUSTRIALISATION
Lauren Orme
West Pharmaceutical Services
FINDING COMMON GROUND: FACTORS FOR ESTABLISHING AND SAFEGUARDING SHELF LIFE IN COMBINATION PRODUCTS
Lauren Orme discusses the regulatory considerations that need to be taken into account when designing combination products. She reviews the essential testing and standards required for both drug and device when establishing their shelf life and storage in a combined product.
CDMOs AS STRATEGIC ENABLERS FOR DEVICE INDUSTRIALISATION
INDUSTRIALISATION
Adam Nightingale
Sanner Group
CDMOs AS STRATEGIC ENABLERS FOR DEVICE INDUSTRIALISATION
Adam Nightingale explores a multitude of approaches to achieving more efficient and sustainable production of medical devices when partnering with a CDMO, and demonstrates the ways in which these partnerships can offer reduced risk and comply with regulations when streamlining industrialisation.
MASTERING COMMERCIAL MANUFACTURING FOR STERILE INJECTABLES
EXPERT VIEW
Jennifer Gattari
MASTERING COMMERCIAL MANUFACTURING FOR STERILE INJECTABLES
Jennifer Gattari delves into what is required to succeed at the commercial phase of sterile injectable manufacturing, going on to explore the challenges that companies can expect and the critical strategies that can help ensure a smooth and scalable journey to market.
SMART ENOUGH: DESIGNING DRUG DELIVERY DEVICES THAT PUT PATIENTS FIRST
EXPERT VIEW
Andy Pidgeon
SMART ENOUGH: DESIGNING DRUG DELIVERY DEVICES THAT PUT PATIENTS FIRST
Andy Pidgeon  challenges the assumption that more advanced technology is always better, re-examining the design approach to connected autoinjectors from the patient perspective and highlighting the value of simplicity and usability – digging into the idea that, by investigating the real-world needs of patients, drug delivery device designers can ensure that their devices are serving those needs, rather than creating unnecessary new challenges for users.
Interview: PDA Miniverse and Trends in Injectable Drug Delivery
INTERVIEW
Mathias Romacker
Kymanox
Interview: PDA Miniverse and Trends in Injectable Drug Delivery
In this exclusive interview, Mathias Romacker and Evan Edwards talk with ONdrugDelivery’s Guy Furness about the upcoming inaugural PDA Miniverse conference in Indianapolis, and the topics and trends currently being felt across the injectable drug delivery industry.
Introducing Instron<sup>®</sup> AVE3 Advanced Video Extensometer
VIDEO
Landon Goldfarb
Instron
Introducing Instron® AVE3 Advanced Video Extensometer
This video introduces Instron’s premier extensometer solution, the AVE3. It is unrivaled in versatility, offering precision strain measurement for tensile, compression, and bend testing.
RETHINKING GLP-1 DELIVERY DEVICES: DESIGNING FOR USERS BEYOND DIABETES
EXPERT VIEW
Dan Lock
RETHINKING GLP-1 DELIVERY DEVICES: DESIGNING FOR USERS BEYOND DIABETES
Dan Lock explores how the experiences and motivations of individuals using glucagon-like peptide 1 drugs for weight loss may differ from those managing diabetes or heart disease.
ADVANCING SUBCUTANEOUS INFUSION THERAPY FOR PATIENTS THROUGH INNOVATION AND PARTNERSHIPS
INJECTION
Julien Vandewalle
Convatec
ADVANCING SUBCUTANEOUS INFUSION THERAPY FOR PATIENTS THROUGH INNOVATION AND PARTNERSHIPS
Julien Vandewalle and Clare Holden explain Convatec’s long-term partnerships with pharmaceutical and medical device companies are driving development in chronic care by introducing subcutaneous technologies that support the treatment of conditions such as diabetes and Parkinson’s disease – showcasing Convatec’s Neria™ Guard infusion set.
Interview: Understanding the Impact of USP<382> on Primary Packaging Development
INTERVIEW
Dr Laure-Helene Guillemot
Aptar Pharma
Interview: Understanding the Impact of USP<382> on Primary Packaging Development
Laure-Hélène Guillemot discusses the new USP <382> chapter coming into force on December 1st, 2025, which will significantly transform functional testing protocols for pharmaceutical companies.
THE POWER OF PARTNERSHIP AND CLOSE COLLABORATION FOR FILLING ON-BODY INJECTORS
WEARABLES
Mary Lou Glotzbach
Grand River Aseptic Manufacturing
THE POWER OF PARTNERSHIP AND CLOSE COLLABORATION FOR FILLING ON-BODY INJECTORS
Mary Lou Glotzbach and Dr Greg Moakes consider the implications of the increasing demand for high-volume injections across the drug delivery industry, and how technologies such as wearable injectors are creating novel challenges for the fill-finish process due to the novel containers involved, making the case that it is only through clear communication and close collaboration between partners that these challenges can be met and surmounted.
PROTECTION AND PRODUCTION: OPTIMISING PRIMARY PACKAGING SOLUTIONS FOR mRNA THERAPIES
INJECTION
Enrico Barichello
Stevanato Group
PROTECTION AND PRODUCTION: OPTIMISING PRIMARY PACKAGING SOLUTIONS FOR mRNA THERAPIES
Enrico Barichello and Riccardo Prete discuss the impact that mRNA-based therapies are having on the modern pharmaceutical market and how these delicate therapies require careful handling, with a particular focus on how Stevanato’s portfolio of primary packaging products can be highly beneficial when bringing these critical medicines to market.
NEXT-GENERATION SURFACE TECHNOLOGIES FOR MEDICAL INJECTION MOULDING
INJECTION
Rob Doorakkers
IGS GeboJagema
NEXT-GENERATION SURFACE TECHNOLOGIES FOR MEDICAL INJECTION MOULDING
Rob Doorakkers of IGS GeboJagema, and Stephan Plassmann of Gloss & Coating, discuss their new Translatio-Coating technology for treating the surfaces of steel parts to achieve microscopic levels of optimisation and open new possibilities for efficiency and quality in drug delivery device manufacturing.
VYTAL – ONE STEP INTO THE FUTURE OF CONTAINER-CLOSURE SYSTEMS
INJECTION
Ana Isabel Gutierrez
H&T Presspart
VYTAL – ONE STEP INTO THE FUTURE OF CONTAINER-CLOSURE SYSTEMS
Ana Isabel Gutierrez looks at advancements in sterile and aseptic filling methods in the pharmaceutical industry, introducing H&T Presspart's Vytal® snap-fit container-closure system, which is designed to meet the growing regulatory demands of the pharmaceutical industry.
GREATER FORMULATION FREEDOM WITH A NOVEL AUTOINJECTOR PLATFORM THAT EXTENDS VOLUME AND VISCOSITY LIMITS
INJECTION
Prof Sigrid Saaler-Reinhardt
Gerresheimer
GREATER FORMULATION FREEDOM WITH A NOVEL AUTOINJECTOR PLATFORM THAT EXTENDS VOLUME AND VISCOSITY LIMITS
Prof Sigrid Saaler-Reinhardt, Dr Andrea Lennerz, Moritz Mond and Marie Stockton discuss how the Gx Inbeneo® autoinjector overcomes the limitations of prefilled syringe-based autoinjectors to provide effective, safe administration of large-volume, high-viscosity formulations.
YES, PEN INJECTORS CAN ACCOMMODATE MORE THAN JUST INSULIN
INJECTION
Cecile Gross
Nemera
YES, PEN INJECTORS CAN ACCOMMODATE MORE THAN JUST INSULIN
Cécile Gross and Mark Tunkel explore the benefits of pen injectors, highlighting their versatility and ease of use, and introduce Nemera’s novel platforms and how they can be adapted for a wide range of indications, enhancing treatment options and the patient experience.
TRANSFORMING PARENTERAL DELIVERY: KEY CONSIDERATIONS FOR SC AND IM FORMULATION DEVELOPMENT
INJECTION
Jeff Clement
PCI Pharma Services
TRANSFORMING PARENTERAL DELIVERY: KEY CONSIDERATIONS FOR SC AND IM FORMULATION DEVELOPMENT
Jeff Clement of PCI looks at the changing landscape of parenteral delivery, considering the pros and cons of intravenous, subcutaneous and intramuscular formulations and considers how new technologies are reshaping the drug delivery landscape.
Top